# Autonomic neurotransmission in cardiovascular regulation and pathophysiology

**Authors:** Fahimeh Varzideh, Stanislovas S. Jankauskas, Pasquale Mone, Urna Kansakar, Gaetano Santulli

PMC · DOI: 10.3389/fnins.2025.1739330 · Frontiers in Neuroscience · 2026-01-26

## TL;DR

This paper explores how the autonomic nervous system controls heart function and how its dysfunction leads to cardiovascular diseases.

## Contribution

The paper provides a comprehensive overview of autonomic neurotransmission mechanisms and their role in cardiovascular health and disease.

## Key findings

- Sympathetic and parasympathetic systems regulate heart rate and vascular tone through distinct neurotransmitters.
- Dysregulation of autonomic balance contributes to hypertension, heart failure, and neuropathy.
- Pharmacologic and non-pharmacologic interventions can restore autonomic balance and improve outcomes.

## Abstract

The autonomic nervous system (ANS) is a central regulator of cardiovascular function, coordinating involuntary control of heart rate, vascular tone, and blood pressure through its sympathetic (SNS) and parasympathetic (PNS) subdivisions. The SNS mediates the “fight or flight” response via catecholamines, increasing heart rate, contractility, and vasoconstriction, whereas the PNS promotes restorative processes through acetylcholine, decreasing heart rate and enhancing vasodilation. Nitric oxide further modulates vascular tone and autonomic balance, serving as a key neuromodulator. Assessment of cardiovascular autonomic function relies on heart rate variability, baroreflex sensitivity, and other physiological tests, which provide insight into the dynamic interplay between sympathetic and parasympathetic activity. Dysregulation of the ANS contributes to cardiovascular pathologies, including cardiovascular autonomic neuropathy, hypertension, and heart failure, where sympathetic overactivity and impaired parasympathetic modulation exacerbate disease progression. Pharmacologic interventions, such as β-blockers and ivabradine, alongside non-pharmacologic approaches, including structured exercise and respiratory training, aim to restore autonomic balance and improve clinical outcomes. Understanding the exact mechanisms of autonomic neurotransmission is essential for identifying novel therapeutic targets and optimizing cardiovascular care. Future research integrating molecular, genetic, and systems-level analyses will further elucidate autonomic regulation, guiding personalized interventions to mitigate cardiovascular morbidity and mortality.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252)

## Full-text entities

- **Diseases:** cardiovascular autonomic neuropathy (MESH:D002318), heart failure (MESH:D006333), hypertension (MESH:D006973)
- **Chemicals:** acetylcholine (MESH:D000109), ivabradine (MESH:D000077550), Nitric oxide (MESH:D009569), catecholamines (MESH:D002395)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883788/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883788/full.md

---
Source: https://tomesphere.com/paper/PMC12883788